Repligen Corp
RGEN Real Time Price USDRecent trades of RGEN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in RGEN holdings by institutional investors
Quarterly net insider trading by RGEN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
RGEN Estimated quarterly lobbying spending
RGEN Revenue by Segment or Geography
New RGEN patent grants
-
Patent Title: Valve assembly with directional flow path Nov. 04, 2025
-
Patent Title: Filtration system and method for synchronizing permeate and retentate flow Sep. 30, 2025
-
Patent Title: Variable path length absorption spectrometer having automated continuous slope measurement Sep. 23, 2025
-
Patent Title: No-ref-signal slope spectroscopic measurement Sep. 09, 2025
-
Patent Title: Encapsulated system for pressurized fluid processes Jul. 29, 2025
-
Patent Title: Tubing coupler moldings and systems, and associated methods Jul. 01, 2025
-
Patent Title: Fc binding proteins with cysteine in the c-terminal helical region Apr. 15, 2025
-
Patent Title: Fc binding proteins with cysteine in the c-terminal helical region Mar. 25, 2025
-
Patent Title: Encapsulated valve system and method of use Mar. 18, 2025
-
Patent Title: Tangential flow filtration systems and methods Feb. 11, 2025
-
Patent Title: Encapsulated valve system and method of use Dec. 31, 2024
-
Patent Title: Tangential flow filtration systems and methods Apr. 16, 2024
-
Patent Title: Micro alternating tangential flow perfusion filter, micro bioreactor, and methods of use thereof Apr. 02, 2024
-
Patent Title: Methods and systems for removing pressure and air from chromatography columns Mar. 26, 2024
-
Patent Title: Pressure gauge relief valve for sterilizable fluid system Mar. 19, 2024
-
Patent Title: Valve assembly with directional flow path Feb. 13, 2024
-
Patent Title: Dual pumping arrangement for a hollow fiber filter Jan. 09, 2024
-
Patent Title: Method of actuation of an alternating tangential flow diaphragm pump Dec. 05, 2023
-
Patent Title: Plunger pumping arrangement for a hollow fiber filter Nov. 14, 2023
-
Patent Title: Fc binding proteins with cysteine in the c-terminal helical region Oct. 10, 2023
-
Patent Title: Encapsulated system for pressurized fluid processes Sep. 12, 2023
-
Patent Title: Encapsulated valve system and method of use Aug. 08, 2023
-
Patent Title: Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber Jun. 20, 2023
-
Patent Title: Filtration system with selective flow reversal Jun. 13, 2023
-
Patent Title: Methods, devices and systems for 3-stage filtration Jun. 06, 2023
-
Patent Title: Tangential flow depth filtration systems and methods of filtration using same May. 09, 2023
-
Patent Title: Tangential flow depth filtration systems and methods of filtration using same May. 09, 2023
-
Patent Title: Flexible tubing management system for pharmaceutical, bioprocess applications, and food/dairy applications Feb. 14, 2023
-
Patent Title: Method of actuation of an alternating tangential flow diaphragm pump Feb. 14, 2023
-
Patent Title: Method of actuation of an alternating tangential flow diaphragm pump Feb. 14, 2023
-
Patent Title: Method for proliferation of cells within a bioreactor using a disposable pumphead and filter assembly Jan. 17, 2023
-
Patent Title: Fc binding proteins with cysteine in the c-terminal helical region Jan. 10, 2023
-
Patent Title: Fluid plug for sterile processes and methods of using the same Dec. 20, 2022
-
Patent Title: Encapsulated system for pressurized fluid processes Dec. 20, 2022
-
Patent Title: Devices, systems, and methods for continuous processing with alternating tangential flow Dec. 13, 2022
-
Patent Title: Devices, systems, and methods for a reducer with an integrated seal Dec. 06, 2022
-
Patent Title: Fluid monitoring assembly with replaceable sensor functionality Nov. 29, 2022
-
Patent Title: Filtration cassette residing in bag and methods of using same Nov. 29, 2022
-
Patent Title: Dual pumping arrangement for a hollow fiber filter Sep. 06, 2022
-
Patent Title: Plunger pumping arrangement for a hollow fiber filter Aug. 30, 2022
-
Patent Title: Methods and systems for removing pressure and air from chromatography columns Jul. 19, 2022
-
Patent Title: Encapsulated system for pressurized fluid processes Jul. 12, 2022
-
Patent Title: Alternating tangential flow rapid harvesting May. 24, 2022
-
Patent Title: Micro alternating tangential flow perfusion filter, micro bioreactor, and methods of use thereof May. 24, 2022
-
Patent Title: Fluid flow monitoring assembly including a flow sensor housing removably secured to a flexible conduit that encapsulates the removable sensor Mar. 15, 2022
-
Patent Title: Flexible tubing management system for pharmaceutical, bioprocess applications, and food/dairy applications Jan. 25, 2022
-
Patent Title: Screen filter module for alternating flow filtration Jun. 12, 2018
-
Patent Title: Device, system and process for modification or concentration of cell-depleted fluid Sep. 20, 2016
-
Patent Title: Screen filter module for alternating flow filtration Jun. 09, 2015
-
Patent Title: Nucleic acids encoding recombinant protein a Apr. 06, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to RGEN from public contracts
Recent insights relating to RGEN
Recent picks made for RGEN stock on CNBC
ETFs with the largest estimated holdings in RGEN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $RGEN stock a Buy, Sell, or Hold?
- What is the price target for $RGEN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RGEN stock?
- Who owns the most shares of $RGEN stock?
- What funds own $RGEN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RGEN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
- Address Waltham, MA
- Market Cap 9.1 billion
- Employees 1,778
- Industrial Classification Biological Products, (No Disgnostic Substances)